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Abstract 
To determine the psychological effects of discontinuation of GH treatment from GH-
treated adults with GH deficiency (GHD), GH replacement was discontinued for 3 
months from 12 of 21 adults, in a double-blind placebo-controlled trial, where 9 
continued with GH. Semi-structured interviews were given at baseline and end-point 
plus questionnaires including a new hormone-deficiency-specific, individualised, 
questionnaire (HDQoL); 2 well-being questionnaires [GWBI, (British version of PGWB) 
and W-BQ12]; and 2 health-status questionnaires [NHP and SF-36]. Ethical Committee 
approval obtained.  
  
Results: Psychological symptoms reported in interviews by placebo-treated patients 
(N=12) included decreased energy (9 patients), increased tiredness (6), pain (5), 
irritability (4), crying episodes (5), depression (4).  Few symptoms were reported by the 
GH-treated group, but between-group differences did not reach significance (Chi-
Square). Treatment-group-by-time interactions for W-BQ12 Energy, SF-36 General 
Health and some HDQoL domains were close to 2-tailed significance, indicating a trend 
towards poorer functioning in these variables in the placebo-treated group by end-
point, and little change in the GH-treated group.  
 
Conclusions: Discontinuation of GH-treatment in GH-deficient adults has detrimental 
psychological effects. Three questionnaires are recommended to measure these 
effects: the HDQoL, the W-BQ12 and SF-36. The frequently-used NHP and GWBI 
were not sensitive to change. This may explain why some previous GH-replacement 
trials have not obtained significant psychological results. Interviews provide useful 
qualitative data and are recommended with small samples.  
